Lygos Biotech, founded by PhD alumni Jeffrey Dietrich and Eric Steen, has raised $13 million in Series A funding to continue their work producing high-value specialty chemicals through synthetic biology. Their process uses domestic sugars instead of petroleum for chemical production, and has already resulted in the world’s first bio-based production of malonic acid.
For the #1 spot in their annual Top 10 Innovations of the year, The Scientist magazine has chosen Milo, the commercial version of the single-cell Western blot technology invented in Professor Amy Herr’s lab. Originally developed for market by BioE PhD alumna Kelly Gardner for their startup Zephyrus Biosciences, acquired by BioTechne, Gardner now runs commercialization of the product for ProteinSimple.
Lief Therapeutics has designed a smart patch that helps people manage their stress through heart rate variability biofeedback. Co-founder Billy Frese is a 2015 BioE MEng alum. Check them out on Kickstarter.
Gauss Surgical, a startup formed by MTM alumnus Siddarth Satish, was listed as one of “80+ Companies Reinventing Medicine” by venture analysis group CB Insights.
John Waldeisen, CEO and Co-founder of Diassess, talks with Wired about the diagnostic tech landscape post-Theranos.
Alumni startup Knox Medical was featured in the Fall 2016 California Magazine, for their child-friendly portable spirometer.
Bioengineering alumni Kelly Gardner and Heather Bowerman have been named top innovators under 35, a list compiled each year by MIT Technology Review. Gardner, PhD 2013 in Amy Herr’s lab, was recognized for her lean biotech startup innovating in single-cell protein analysis. Bowerman, BS 2005, was honored for inexpensive hormone level tracking technology. They are two of the seven UC Berkeley-affiliated engineers named this year.
This BioE startup uses a video game to predict kids’ asthma attacks.
BioE startup Magnetic Insight will install their first Magnetic Particle Imaging scanner at the Stanford School of Medicine, where researchers will explore using MPI to solve challenges in cell therapy and vascular imaging. The company, led by PhD alumnus Patrick Goodwill and BioE professor Steven Conolly, has also recently secured an oversubscribed seed funding round of $3M.